Expert Review of Gastroenterology & Hepatology

Article	Citations
Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how?	42
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors	39
Managing pain in irritable bowel syndrome: current perspectives and best practice	32
Leucine-rich alpha-2 glycoprotein as a blood biomarker in inflammatory bowel disease: clinical implications and future perspectives	31
Impact of yoga therapy in intestinal disorders	29
Addressing current limitations of colonoscopy for colorectal cancer screening	28
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions	27
Targeting liver metabolism: a pathway to cure hepatitis B virus?	27
Small bowel transplant – novel indications and recent progress	27
Therapeutic drug monitoring in inflammatory bowel disease: recent developments	26
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences	25
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis	25
Recent advances in treating constipation in children	24
Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms	22
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?	22
Gender-related differences in celiac disease presentation and follow-up in adult patients	22
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)	21
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease	21
Elucidating the role of extracellular vesicles in liver injury induced by HIV	21
A narrative review on the diagnosis and management of constipation in infants	20
The assessment of impaired liver function and prognosis in hepatocellular carcinoma	19
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites	19
Irritable bowel syndrome – controversies in diagnosis and management	19
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management	19
The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review	18

Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities	18
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice	18
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction	18
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	18
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice	17
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment	17
Managing bile acid diarrhea: aspects of contention	17
Investigating the correlation between COVID-19 and the progression of chronic liver disease	17
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract	17
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?	16
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis	15
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis	15
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont	15
Small bowel imaging in inflammatory bowel disease: updates for 2023	15
IBD in women of reproductive age: where do novel therapies fit in?	14
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States	14
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective	13
Updates on intestinal failure management	13
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery	13
Evaluating the role of endoscopic ultrasound in pancreatitis	13
Psychological distress in inflammatory bowel disease	13
The impact of a multidisciplinary team evaluation on the diagnosis and management of acute and chronic pancreatitis in a tertiary referral center	13
Techniques and outcomes review of the endoscopic management of gastrointestinal bleeding	12
Noninvasive diagnosis of clinically significant portal hypertension: current evidence and future directions	12
Contemporary epidemiology of metabolic dysfunction-associated steatotic liver disease	12
Carcinoid syndrome mimicking irritable bowel syndrome: don’t fall into the trap	12
EUS-guided choledochoduodenostomy (EUS-CDS) with lumen-apposing metal stents (LAMS): a comprehensive technical review	12
Managing pediatric Crohn’s disease: recent insights	12
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives	11
Diagnosing eosinophilic esophagitis in pediatric patients	11
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review	11
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays	11
Gastroesophageal reflux disease in preterm infants: unmet needs	11
Managing complications of chronic pancreatitis: a guide for the gastroenterologist	11
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma	10
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation	10
Management of disease-related abdominal abscesses in Crohn’s disease	10
Towards a better diagnosis of gastro esophageal reflux disease	10
Clinical management of inflammatory bowel disease from preconception to postpartum	10
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults	10
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art	10
Safety and use of IBD therapies during pregnancy and lactation	10
Optimizing nutritional care across the continuum from intensive care to recovery: an expert opinion review	10
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis	10
Reply to letter to the Editor: Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	10
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis	10
Highlighting novel targets in immunotherapy for liver cancer	10
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study	10
Endoscopic follow-up in patients with first-degree relatives for gastric cancer: a real-world observational study	9
The TL1A inhibitors in IBD: what’s in the pot?	9

Rome V criteria for pediatric disorders of gut – brain interaction: key updates and clinical implications	9
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece	9
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease	9
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview	9
Characterizing Crohn’s disease phenotypes through pan-enteric capsule endoscopy	9
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights	9
PSC patient with jaundice – should we ERCP?	9
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges	9
Introducing the “Guideline Comparison” article type	9
Acute severe ulcerative colitis: defining the precise moment for colectomy	8
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease	8
Nutritional aspects of inflammatory bowel disease	8
Prioritization in inflammatory bowel disease therapy	8
2023 update on the clinical management of gastroparesis	8
Medical management of acute severe ulcerative colitis in the hospitalized patient	8
Microbial ecology and hepatocellular carcinoma: should a subset be viewed as a microbiome-conditioned malignancy?	8
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity	8
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect	8
Clinical role of anti-PD-1 immunotherapies in esophageal cancer	8
Induction and maintenance of healing in erosive esophagitis in the United States	8
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease	8
Systematic mapping of worldwide research on intra-pancreatic fat deposition	8
Histamine-producing bacteria and their role in gastrointestinal disorders	8
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis	8
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review	8
Radiation safety and dose management in fluoroscopy-guided gastrointestinal procedures: current evidence and future perspectives	8
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis	8
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors	7
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure	7
Lyon Consensus 2.0: what has changed for GERD diagnosis?	7
Before the scope: precision medicine in medication management for endoscopic safety and quality	7
A contemporary review of care gaps in hepatocellular carcinoma surveillance	7
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities	7
Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI)	7
Proton beam therapy in the management of hepatocellular carcinoma	7
The eternal dichotomy between early biologic therapy and early surgery in Crohn’s disease: which should truly take precedence?	7
Adenoma detection rate in colonoscopy: how can it be improved?	7
Recent advances in the treatment of gastrointestinal motility disorders in children	7
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease	7
Noninvasive electrical neuromodulation for gastrointestinal motility disorders	7
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review	7
Significance of nucleologenesis, ribogenesis, and nucleolar proteome in the pathogenesis and recurrence of hepatocellular carcinoma	7
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan	7
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis	7
Short bowel syndrome-associated intestinal failure: diagnosis and prognosis	7
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms	7
To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease	7
Recent developments in the therapeutic management of acid-related gastrointestinal diseases	7
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review	7
Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals	6
Evaluating the molecular and genetic mechanisms underlying gut motility disorders	6
Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study	6
Update on biliary endoscopy: a comprehensive review	6
Strengths and limitations of risk stratification tools for patients with upper gastrointestinal bleeding: a narrative review	6
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus	6
Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study	6
Is high resolution manometry pertinent in eosinophilic esophagitis assessment?	6
Securing the diagnosis of HRS-AKI: implications for current therapies	6
The emerging roles of intestinal organoid models in inflammatory bowel disease research	6
Etiologic factors for Barrett’s esophagus: toward countermeasures in Asia	6
Stratification of obesity phenotypes to optimize future therapy (SOPHIA)	6
Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis	6
Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease	6
Screening for MASLD in patients with type 2 diabetes: is an early diagnosis a good diagnosis?	6
What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?	6
Advancements in the prevention and management of postoperative Crohn’s disease recurrence	6
Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database	6
Letter to the editor: vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis	6
Endoscopic ultrasonography guided gallbladder drainage: “how and when”	6
Comprehensive care of ulcerative colitis: new treatment strategies	6
Diagnosing and managing gastroparesis - where are we now?	5
Clinical efficacy and safety of robot assisted surgery for choledochal cysts excisions: a systematic review and meta-analysis	5
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injury	5
Screening for pancreatic cancer has the potential to save lives, but is it practical?	5
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making	5
Cold resection for colorectal polyps: where we are and where we are going?	5
Ulcerative colitis, frailty, and beyond	5
Occult hepatitis B infection – unveiling clinical burden and new diagnostic strategies	5
Sleeve gastrectomy with transit bipartition: a review of the literature	5
From liver to gut: the hidden gastrointestinal impact of pediatric metabolic dysfunction-associated steatotic liver disease	5

Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective	5
How to predict abnormal acid reflux: recent developments	5
Spontaneous swallowing frequency in the evaluation of swallowing function	5
Hepatobiliary disease after bone marrow transplant	5
Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages	5
Filgotinib for moderately to severely active ulcerative colitis	5
Irritable bowel syndrome in the elderly: epidemiology, diagnosis, treatment, and relationship with frailty	5
Antireflux surgery – choosing the right candidate	5
Dual energy computed tomography in Crohn’s disease: a targeted review	5
CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis	5
Therapeutic effect of ustekinumab on patients with extra-intestinal manifestations of Crohn’s disease	5
Mistakes in utilising histopathology for the management of liver disease	4
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry	4
Is oncolytic adenoviral-mediated immunotherapy through p53-overexpression the solution to refractory pancreatic ductal adenocarcinoma?	4
EUS-guided tissue acquisition: past achievements, current challenges and future directions	4
Antireflux surgeries and hiatal repair: keys to success	4
Abdominal pain in children: guidelines at last	4
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics	4
Advances in target drugs and immunotherapy for biliary tract cancer	4
An overview of the efficacy, safety, and predictors of achalasia treatments	4
Impact of GLP-1 receptor agonists on gastrointestinal function and symptoms	4
Endoscopic ultrasound guided liver biopsy and portal pressure gradient: when, why and how? Can it become the standard of care in endo-hepatology?	4
The non-surgical therapy of uncomplicated gallbladder stones: is there a niche?	4
Electrosurgical unit in GI endoscopy: the proper settings for practice	4
The necessity and safety of simultaneous cholecystectomy during gastric surgery for patients with asymptomatic cholelithiasis	4
Antibiotics in decompensated liver disease – who, when and for how long?	4
Identifying and managing rare subtypes of gastrointestinal stromal tumors	4
Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome	4
Novel approaches in the medical management of compensated cirrhosis	4
Validated approaches at mayo clinic for measuring gastric and colonic transit of solids and gastric accommodation	4
Revolutionizing liver fibrosis research: the promise of 3D organoid models in understanding and treating chronic liver disease	4
Gastrointestinal reported outcomes following one anastomosis gastric bypass based on a multicenter study	4
The clinical implications of trial endpoints in immunotherapy for hepatocellular carcinoma	3
Multiparametric intestinal ultrasound in inflammatory bowel diseases: a narrative review	3
Metabolic dysfunction-associated steatotic liver disease and gastrointestinal cancer risk in youth: is it time to unveil a hidden link?	3
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials	3
Therapeutics for Clostridioides difficile infection: molecules and microbes	3
Guideline comparison for fatty liver disease: European (EASL-EASD-EASO) and Asian (APASL) perspectives	3
FAPI PET in inflammatory bowel disease: a novel window on fibroblast activity, with unanswered clinical questions	3
Imaging in MASLD	3
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the	3
Training in diagnostic and interventional endoscopic ultrasound: a state-of-the-art review	3
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?	3
A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children	3
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients	3
Eosinophilic esophagitis in the era of biologics	3
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review	3
Research progress on short-term prognosis of acute-on-chronic liver failure	3
New progress with calcium-binding protein S100A16 in digestive system disease	3
Unraveling the link: diagnosing metabolic dysfunction-associated steatotic liver disease in the context of decompensated cirrhosis	3
A critical review of technical progress, clinical heterogeneity, and implementation challenges of artificial intelligence in digestive endoscopy	3
Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis	3
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis	3
Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review	3
Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy	3
Gastric acid secretion therapy: long-term effects on gastric mucosa and polyp formation	3
Cirrhosis and non-hepatic surgery in 2023 – a precision medicine approach	3
The role of videocapsule endoscopy in the diagnosis and follow-up of celiac disease: a scoping review	3
Management of gastric varices: treatment options and opportunities to improve outcomes	3
The role of microRNAs on the pathogenesis, diagnosis and management of portal hypertension in patients with chronic liver disease	3
Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study	3
Hemostatic powders and gels in gastrointestinal endoscopy: current perspective and future recommendations	3
Achalasia, from diagnosis to treatment	3
Serological testing for celiac disease in children	3
Risk factors for recurrent common bile duct stones: a systematic review and meta-analysis	3
A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments	3
What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?	3
Response to letter: ‘Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction’	3
Adjuvant therapy in biliary tract tumors: how will immunotherapy fit in the future?	3
Same versus separate sessions of endoscopic ultrasound-guided fine-needle biopsy and endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction: a propensity score-matched	3